Danapha Pharmaceutical JSC (HSTC:DAN) Interest Expense: ₫ Mil (TTM As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Interest Expense?

Danapha Pharmaceutical JSC HSTC:DAN 31 Interest Expense is ₫ Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Danapha Pharmaceutical JSC's interest expense for the six months ended in . 20 was ₫ 0.00 Mil. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Danapha Pharmaceutical JSC's Operating Income for the six months ended in . 20 was ₫ 0.00 Mil. Danapha Pharmaceutical JSC's Interest Expense for the six months ended in . 20 was ₫ 0.00 Mil. Danapha Pharmaceutical JSC did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Danapha Pharmaceutical JSC  (HSTC:DAN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Danapha Pharmaceutical JSC's Interest Expense for the six months ended in . 20 was ₫0.00 Mil. Its Operating Income for the six months ended in . 20 was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC's Interest Coverage for the quarter that ended in . 20 is calculated as

Danapha Pharmaceutical JSC had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Danapha Pharmaceutical JSC Interest Expense Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Interest Expense Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Interest Expense

Danapha Pharmaceutical JSC Semi-Annual Data
Interest Expense
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₫ Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Interest Expense of ₫ Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Interest Expense too high?
Danapha Pharmaceutical JSC's current Interest Expense is ₫ Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Interest Expense compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Interest Expense of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Interest Expense is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Interest Expense of ₫ Mil. The current Interest Expense is ₫ Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Interest Expense is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price